Stay updated on AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial
Sign up to get notified when there's something new on the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page.

Latest updates to the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing Revision: v3.6.2, indicating a minor platform update. No study content or details appear to be changed.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2, representing a maintenance release of the page's platform. The change does not modify study details or content visible to users.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRecruitment status on the study page was updated to 'No longer looking for participants', and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). A heading formatting change (Intervention/Treatment) and a revision note (Revision: v3.6.0) were also applied.SummaryDifference0.4%

- Check30 days agoChange DetectedThe page's revision indicator has been updated from v3.5.4 to v3.5.5, replacing the previous version and signaling an updated revision of the document metadata.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the page or system. This appears to be a routine update and does not imply changes to the study data or eligibility criteria.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision label changed from v3.5.2 to v3.5.3, indicating a new build of the page. It represents a maintenance update rather than a change to substantive content or features.SummaryDifference0.1%

Stay in the know with updates to AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page.